<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03171467</url>
  </required_header>
  <id_info>
    <org_study_id>SaLCHE</org_study_id>
    <nct_id>NCT03171467</nct_id>
  </id_info>
  <brief_title>Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)</brief_title>
  <acronym>SaLCHE</acronym>
  <official_title>Salpingectomy in Women Undergoing Elective Laparoscopic Cholecystectomy (SaLCHE): A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Krankenhaus der Barmherzigen Brüder Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Krankenhaus der Elisabethinen Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Landeskrankenhaus Feldbach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LKH Hartberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Krankenhaus der Barmherzigen Brüder St. Veit/Glan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prophylactic salpingectomy (also called opportunistic, risk-reducing or incidental
      salpingectomy) has been advocated at the time of gynecologic surgery to reduce the risk of
      serous ovarian cancer. This study explores the acceptability and feasibility of opportunistic
      salpingectomy at the time of elective laparoscopic cholecystectomy (LCHE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many serous ovarian cancers are now thought to originate in the fimbria of the fallopian
      tubes. This has led a number of professional societies worldwide to recommend consideration
      of prophylactic salpingectomy at the time of elective gynecologic surgery or tubal
      sterilization.

      This study explores the acceptability and feasibility of incidental (opportunistic,
      risk-reducing, prophylactic) salpingectomy at the time of a common nongynecologic procedure
      in women, i.e. elective laparoscopic cholecystectomy (LCHE). The study addresses whether
      women ≥45 years would accept opportunistic salpingectomy and the technical feasibility (time,
      port placement, complications) in women who consented to salpingectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">April 1, 2018</completion_date>
  <primary_completion_date type="Actual">April 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of opportunistic bilateral salpingectomy at the time of laparoscopic cholecystectomy</measure>
    <time_frame>At time of laparoscopic cholecystectomy surgery</time_frame>
    <description>Evaluation of how often opportunistic bilateral salpingectomy can be accomplished at the time of laparoscopic cholecystectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time</measure>
    <time_frame>At the time of surgery</time_frame>
    <description>Time (in minutes) from completion of cholecystectomy to completion of bilateral salpingectomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Port repositioning</measure>
    <time_frame>At surgery</time_frame>
    <description>Rate of port repositioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Number of complications due to salpingectomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-recorded outcome</measure>
    <time_frame>Preop. and 1 year</time_frame>
    <description>Bliem Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Prophylactic Salpingectomy</condition>
  <condition>Opportunistic Salpingectomy</condition>
  <condition>Laparoscopic Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>Salpingectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Opportunistic salpingectomy at the time of laparoscopic cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Salpingectomy</intervention_name>
    <arm_group_label>Salpingectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled (elective) laparoscopic cholecystectomy for a benign indication

          -  Age &gt;45 years

          -  Consent

        Exclusion Criteria:

          -  Age &lt;45 years

          -  Desire to preserve fertility

          -  Cholecystectomy for malignant disease

          -  Extensive previous abdominal surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl F Tamussino, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Landeskrankenhaus Feldbach</name>
      <address>
        <city>Feldbach</city>
        <zip>8330</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder Graz</name>
      <address>
        <city>Graz</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Elisabethinen Graz</name>
      <address>
        <city>Graz</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Hartberg</name>
      <address>
        <city>Hartberg</city>
        <zip>8230</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder St. Veit/Glan</name>
      <address>
        <city>St. Veit/Glan</city>
        <zip>9300</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Long Roche KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O. Risk-reducing salpingectomy: Let us be opportunistic. Cancer. 2017 May 15;123(10):1714-1720. doi: 10.1002/cncr.30528. Epub 2017 Mar 23. Review.</citation>
    <PMID>28334425</PMID>
  </reference>
  <reference>
    <citation>Committee on Gynecologic Practice. Committee opinion no. 620: Salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015 Jan;125(1):279-81. doi: 10.1097/01.AOG.0000459871.88564.09. Erratum in: Obstet Gynecol. 2016 Feb;127(2):405. Obstet Gynecol. 2016 Feb;127(2):405.</citation>
    <PMID>25560145</PMID>
  </reference>
  <reference>
    <citation>Falconer H, Yin L, Grönberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015 Jan 27;107(2). pii: dju410. doi: 10.1093/jnci/dju410. Print 2015 Feb.</citation>
    <PMID>25628372</PMID>
  </reference>
  <reference>
    <citation>Kurman RJ, Shih IeM. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol. 2016 Apr;186(4):733-47. doi: 10.1016/j.ajpath.2015.11.011. Review.</citation>
    <PMID>27012190</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>May 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

